COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Camrelizumab With AC in Patients With Brain Metastases of Driven Gene-negative,NSCLC (CAP-BRAIN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04211090
Recruitment Status : Recruiting
First Posted : December 26, 2019
Last Update Posted : December 30, 2019
Jiangsu HengRui Medicine Co., Ltd.
Information provided by (Responsible Party):
Li-kun Chen, Sun Yat-sen University

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 15, 2022
Estimated Study Completion Date : July 15, 2023